Intensity Therapeutics公司宣布,其Int230-6相关研究已经完成,累计入组患者人数超过200名。该研究取得的成果现已通过严格的同行评审程序,并在专业学术期刊上正式发表。
Intensity Therapeutics公司宣布,其Int230-6相关研究已经完成,累计入组患者人数超过200名。该研究取得的成果现已通过严格的同行评审程序,并在专业学术期刊上正式发表。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.